Search Results - "Flores, B T"

  • Showing 1 - 20 results of 20
Refine Results
  1. 1

    Implantable cardioverter-defibrillator therapy in the absence of significant symptoms : rhythm diagnosis and management aided by stored electrogram analysis by HOOK, B. G, CELLANS, D. J, KLEIMAN, R. B, FLORES, B. T, MARCHLINSKI, F. E

    Published in Circulation (New York, N.Y.) (01-06-1993)
    “…This report describes the value of stored ventricular electrogram analysis in the diagnosis and management of patients experiencing minimal or no symptoms…”
    Get full text
    Journal Article
  2. 2

    The automatic implantable cardioverter-defibrillator: efficacy, complications, and device failures by Marchlinski, F E, Flores, B T, Buxton, A E, Hargrove, 3rd, W C, Addonizio, V P, Stephenson, L W, Harken, A H, Doherty, J U, Grogan, Jr, E W, Josephson, M E

    Published in Annals of internal medicine (01-04-1986)
    “…Twenty-six patients with refractory ventricular arrhythmias received the automatic implantable cardioverter-defibrillator. A patch lead only was placed during…”
    Get more information
    Journal Article
  3. 3

    Nonsustained ventricular tachycardia in patients with coronary artery disease: role of electrophysiologic study by BUXTON, A. E, MARCHLINSKI, F. E, FLORES, B. T, MILLER, J. M, DOHERTY, J. U, JOSEPHSON, M. E

    Published in Circulation (New York, N.Y.) (01-06-1987)
    “…Sixty-two consecutive patients with chronic coronary artery disease referred for evaluation of nonsustained ventricular tachycardia (VT) underwent…”
    Get full text
    Journal Article
  4. 4

    Unique sensing errors in third-generation implantable cardioverter-defibrillators by Callans, David J., Hook, Bruce G., Kleiman, Robert B., Mitra, Raman L., Flores, Belinda T., Marchlinski, Francis E.

    “…Objectives. Third-generation cardioverter-defibrillators appear to be susceptible to unique sensing errors. This study was performed to determine the incidence…”
    Get full text
    Journal Article
  5. 5

    Importance of abortive shock capability with electrogram storage in cardioverter-defibrillator devices by Hurwitz, Jodie L., Hook, Bruce G., Flores, Belinda T., Marchlinski, Francis E.

    “…Objectives. This study evaluates the ability of a third-generation cardioverter-defibrillator to abort energy delivery and the importance of electrogram…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Prognostic factors in nonsustained ventricular tachycardia by Buxton, Alfred E., Marchlinski, Francis E., Waxman, Harvey L., Flores, Belinda T., Cassidy, Dennis M., Josephson, Mark E.

    Published in The American journal of cardiology (01-05-1984)
    “…Electrophysiologic studies were performed in 83 consecutive patients with spontaneous nonsustained ventricular tachycardia (VT). VT was inducible in 52…”
    Get full text
    Journal Article
  8. 8

    Amiodarone versus amiodarone and a type IA agent for treatment of patients with rapid ventricular tachycardia by MARCHLINSKI, F. E, BUXTON, A. E, MILLER, J. M, VASSALLO, J. A, FLORES, B. T, JOSEPHSON, M. E

    Published in Circulation (New York, N.Y.) (01-11-1986)
    “…Induction of rapid ventricular tachycardia or fibrillation during therapy with amiodarone is associated with an increased risk of sudden death. To determine…”
    Get full text
    Journal Article
  9. 9

    Shock occurrence and survival in 241 patients with implantable cardioverter-defibrillator therapy by Grimm, W, Flores, B T, Marchlinski, F E

    Published in Circulation (New York, N.Y.) (01-06-1993)
    “…The purpose of this study was to determine the influence of clinical characteristics on shock occurrence and survival in 241 patients with implantable…”
    Get full text
    Journal Article
  10. 10

    Relationship of steady-state serum concentrations of amiodarone and desethylamiodarone to therapeutic efficacy and adverse effects by Falik, R, Flores, B T, Shaw, L, Gibson, G A, Josephson, M E, Marchlinski, F E

    Published in The American journal of medicine (01-06-1987)
    “…The relationship of steady-state serum levels of amiodarone and its major metabolite, desethylamiodarone, to therapeutic and toxic effects was evaluated in 111…”
    Get more information
    Journal Article
  11. 11
  12. 12

    Early postoperative increase in defibrillation threshold with nonthoracotomy system in humans by Hsia, H H, Mitra, R L, Flores, B T, Marchlinski, F E

    Published in Pacing and clinical electrophysiology (01-06-1994)
    “…The stability of the defibrillation threshold (DFT) early after implantation of an implantable cardioverter defibrillator was evaluated in 15 patients. All but…”
    Get more information
    Journal Article
  13. 13

    Efficacy of antitachycardia pacing in patients presenting with cardiac arrest by Mitra, R L, Hsia, H H, Hook, B G, Callans, D J, Flores, B T, Miller, J M, Josephson, M E, Marchlinski, F E

    Published in Pacing and clinical electrophysiology (01-11-1995)
    “…The efficacy of antitachycardia pacing (ATP) incorporated into implantable cardioverter defibrillators (ICDs) was assessed in 29 consecutive survivors of…”
    Get more information
    Journal Article
  14. 14

    Comparison of simultaneous versus sequential defibrillation pulsing techniques using a nonthoracotomy system by Hsia, H H, Kleiman, R B, Flores, B T, Marchlinski, F E

    Published in Pacing and clinical electrophysiology (01-07-1994)
    “…The defibrillation threshold (DFT) using simultaneous (SIML) versus sequential (SEQ) pathways for shock delivery was compared in 16 patients with an implanted…”
    Get more information
    Journal Article
  15. 15

    Acute and chronic cycle length dependent increase in ventricular pacing threshold by Hook, B G, Perlman, R L, Callans, D J, Hanna, M S, Kleiman, R B, Flores, B T, Marchlinski, F E

    Published in Pacing and clinical electrophysiology (01-10-1992)
    “…Several factors have been shown to influence ventricular pacing threshold in humans, including pacing lead location (endocardial vs epicardial), lead…”
    Get more information
    Journal Article
  16. 16

    Value of Holter monitoring in identifying risk for sustained ventricular arrhythmia recurrence on amiodarone by Marchlinski, Francis E., Buxton, Alfred E., Flores, Belinda T., Doherty, John U., Waxman, Harvey L., Josephson, Mark E.

    Published in The American journal of cardiology (01-03-1985)
    “…Seventy-four patients with sustained ventricular tachyarrhythmias had 22 ± 3 hours of Holter monitoring before and after 11 ± 6 days of amiodarone treatment…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20